abstract |
The present invention relates to stable oral pharmaceutical formulations comprising candesartan cilexetil with an antioxidant that acts as an excellent stabilizer and to a processes for manufacturing the same, possibly together with at least one chelating agent that enhances the stability, optionally in combination with a diuretic, hydrochlorothiazide (HCTZ). |